Randomized Phase 1 Studies Evaluating the Safety, Tolerability, Pharmacokinetics, and Target Occupancy of Zampilimab in Healthy Participants. [PDF]
Collier J +10 more
europepmc +1 more source
GLP-1-based therapeutics for cardiorenal protection in metabolic diseases. [PDF]
Apperloo EM +3 more
europepmc +1 more source
New Insights into Radical Mechanisms in Natural Drying Oils: Paint Binders as Reactors for Nanoparticle Formation. [PDF]
de Viguerie L +7 more
europepmc +1 more source
Carbon enriched mixed metal oxides as novel nanocomposites for efficient brilliant green decontamination. [PDF]
Abdelrahman EA, Alashqar S.
europepmc +1 more source
Weekly Subcutaneous VK2735, a GIP/GLP-1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13-Week VENTURE Study. [PDF]
Bays HE +9 more
europepmc +1 more source
Pharmacologic treatment of obesity in adults: Standards of care in overweight and obesity. [PDF]
American Diabetes Association Professional Practice Committee for Obesity.
europepmc +1 more source
Does HLA-B27 Status Influence Ixekizumab Efficacy in Axial Spondyloarthritis? Results From the COAST-V, COAST-W, and COAST-X Trials. [PDF]
Reveille JD +11 more
europepmc +1 more source
Post-Hoc Analysis on the Effects of Vicadrostat/Empagliflozin by CKD Severity/Hypertension Status. [PDF]
Correa-Rotter R +14 more
europepmc +1 more source
Clinical Benefits and Safety of Multiple Micronutrient Supplementation During Preconception, Pregnancy, and Lactation: A Review. [PDF]
Liu J +8 more
europepmc +1 more source
Characterization of insecticide resistance mechanisms in the Anopheles gambiae population of Sierra Leone. [PDF]
Opondo KO +15 more
europepmc +1 more source

